Intensity Therapeutics adopts amended bylaws to strengthen shareholder proposal procedures

INTENSITY THERAPEUTICS, INC.

Board adopted Second Amended and Restated Bylaws on Nov 21, 2023, effective immediately.
Amendments require enhanced disclosures from nominating shareholders, proposed nominees, and related persons.
New provisions address Rule 14a-19 universal proxy and Rule 14a-8 shareholder proposals.
Includes other ministerial, clarifying, and conforming changes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INTENSITY THERAPEUTICS, INC.: Board adopted second amended and restated bylaws effective immediately, enhancing procedural mechanics for shareholder nominations and making other updates (effective 2023-11-21).

Change: bylaw amendment
Effective: 2023-11-21

Exact text from the filing

On November 21, 2023, the board of directors of Intensity Therapeutics, Inc. (the “Company”) adopted the second amended and restated bylaws (the “Second Amended and Restated Bylaws”), effective immediately.

View on SEC.gov

Browse all governance changes →

INTENSITY THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-23-089612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.